GlassScriptPhysician profile
Amy York
NPI 1962580985
$2,318.74
in general payments reported to CMS, 2019-2025
31 companies · $583 in 2025
The $583 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $485 · 2022: $380 · 2023: $425 · 2024: $445 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $285.89 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $237.99 | 2021-2022 | |
| Abbvie INC. | $198.12 | 2024-2025 | |
| Novo Nordisk INC | $169.90 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $148.95 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.42 | 2021-2022 | |
| Pfizer INC. | $116.46 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $106.12 | 2021-2023 | Farxiga, Breztri |
| Otsuka America Pharmaceutical, INC. | $103.10 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $91.85 | 2021-2024 | |
| Dexcom, INC. | $83.31 | 2024-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $77.24 | 2021-2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $70.59 | 2023-2025 | Trelegy Ellipta |
| Abiomed | $61.44 | 2023-2025 | Impella |
| Eisai INC. | $53.22 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $35.45 | 2024 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.97 | 2022-2023 | Tradjenta, Jardiance, Synjardy |
| Lundbeck LLC | $33.81 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $31.96 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $30.73 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.11 | 2021-2025 | Capvaxive |
| Phathom Pharmaceuticals, INC. | $25.68 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $24.86 | 2022 | |
| Edwards Lifesciences Corporation | $22.51 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biosense Webster, INC. | $21.41 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.33 | 2024 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $19.05 | 2025 | |
| Medtronic, INC. | $18.40 | 2025 | Intellis Adaptivestim |
| Seagen INC. | $15.41 | 2022 | |
| Abbott Laboratories | $14.87 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy York listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.